Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel.
An Bras Dermatol
; 95(2): 221-237, 2020.
Article
en En
| MEDLINE
| ID: mdl-32165025
With the development of new cancer therapies, systemic toxicity profile and effects on survival achieved an important improvement. However, a constellation of toxicities has emerged, even more remarkably, cutaneous adverse events. This report, developed by a board of Brazilian experts in oncodermatology, aims to establish a guideline for the dermatological care of oncologic patients. When possible, evidence-based recommendations were made, but in many cases, when strong evidence was not available, a consensus was reached, based on some data supporting therapies combined with personal experiences.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Enfermedades de la Piel
/
Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos
/
Neoplasias
/
Antineoplásicos
Tipo de estudio:
Etiology_studies
/
Guideline
/
Risk_factors_studies
Límite:
Humans
Idioma:
En
Revista:
An Bras Dermatol
Año:
2020
Tipo del documento:
Article
Pais de publicación:
España